The Journal of Urology
Volume 179, Issue 2 , Pages 461-467, February 2008

Trends in the Use of Gross and Frozen Section Pathological Consultations During Partial or Radical Nephrectomy for Renal Cell Carcinoma

  • David C. Miller

      Affiliations

    • Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California
    • Jonsson Comprehensive Cancer Center, University of California-Los Angeles, Los Angeles, California
  • ,
  • Rajal B. Shah

      Affiliations

    • Departments of Pathology and Urology, University of Michigan Medical School, Ann Arbor, Michigan
  • ,
  • Aron Bruhn

      Affiliations

    • Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California
  • ,
  • Rodger Madison

      Affiliations

    • RAND Corp., Santa Monica, California
  • ,
  • Christopher S. Saigal

      Affiliations

    • Department of Urology, David Geffen School of Medicine, University of California-Los Angeles, Los Angeles, California
    • RAND Corp., Santa Monica, California
    • Corresponding Author InformationCorrespondence: Department of Urology, University of California-Los Angeles, Box 951738, Los Angeles, California 90095-1738 (telephone: 310-206-8183; FAX: 310-206-5343).
  • ,
  • Urologic Diseases in America Project

Received 29 May 2007 published online 12 December 2007.

To access this article, please choose from the options below

Login to an existing account or Register a new account.

  • Purchase this article for 30.00 USD (You must login/register to purchase this article)

    Online access for 24 hours. The PDF version can be downloaded as your permanent record.

  • Subscribe to this title

    Get unlimited online access to this article and all other articles in this title 24/7 for one year.

  • Claim access now

    For current subscribers with Society Membership or Account Number.

  • Visit SciVerse ScienceDirect to see if you have access via your institution.

 Study received approval from the University of California-Los Angeles institutional review board.

 Supported by the National Institute of Diabetes, Digestive and Kidney Diseases, National Cancer Institute NIH-1-F32 CA123819-01 (DCM), American Cancer Society PF CPHPS-112124 (DCM) and the American Urological Association Foundation Research Scholar Program (DCM).

PII: S0022-5347(07)02541-4

doi:10.1016/j.juro.2007.09.041

The Journal of Urology
Volume 179, Issue 2 , Pages 461-467, February 2008